


Type
Skin Analysis
Duration
45 min
AKESO Dermatologie uses the FotoFinder digital dermoscopy system — one of the world's leading AI-assisted mole monitoring platforms — for full-body mole mapping and skin cancer screening. The examination involves systematic photographing and dermoscopic analysis of every pigmented lesion across the body, creating a digital baseline that can be compared in future visits to detect changes over time. Suspicious lesions are assessed using AI-assisted pattern recognition alongside dermatologist review. The 3,000 Kč session includes a full-body scan and written report; surgical removal of flagged lesions is available from an additional 1,300 Kč.
Dermoscopy is a non-invasive examination technique that uses a polarised or immersion-contact lens system to illuminate the skin surface and visualise subsurface structures — including pigment distribution, vessel patterns, and architectural features — that are invisible to the naked eye. Digital dermoscopy extends this by capturing standardised photographic records of every lesion, enabling longitudinal monitoring and AI-assisted pattern analysis. The FotoFinder system used at AKESO Dermatologie is an internationally validated platform used in leading European dermatology departments. The device's AI algorithms have been trained on millions of classified dermoscopic images and can flag features associated with melanoma, basal cell carcinoma, and squamous cell carcinoma with a sensitivity that supplements — and in pattern recognition tasks, compares favourably to — experienced dermatologists. A full-body session proceeds as follows: 1. **Preparation:** The patient changes into a gown. All body surfaces accessible to the camera are documented. 2. **Wide-field body photography:** The FotoFinder's body scanner captures standardised images of the entire skin surface to map lesion locations. 3. **Dermoscopic close-ups:** Every clinically relevant pigmented lesion is photographed under dermoscopic magnification and documented with GPS coordinates relative to the body map. 4. **AI-assisted analysis:** The system flags lesions with concerning feature profiles for focused dermatologist review. 5. **Clinical assessment:** The dermatologist evaluates flagged and borderline lesions, classifying each as benign, watchful waiting, or requiring excision. 6. **Written report:** A structured report documents the findings, lists any lesions requiring monitoring or removal, and provides baseline images for future comparison. The session costs 3,000 Kč. If any lesion is assessed as suspicious and requires surgical excision, removal is performed in the same appointment or a follow-up visit from an additional 1,300 Kč, with histopathological analysis available to confirm the diagnosis. Mole mapping is recommended for adults with more than 50 moles, a personal or family history of melanoma, significant sun exposure history, or immunosuppression. Annual re-mapping at AKESO allows any new or changed lesions to be identified early — the window in which melanoma treatment success rates are highest.
Key Details
- System
- FotoFinder digital dermoscopy
- Full-body mapping
- 3,000 Kč
- Lesion removal (if needed)
- From 1,300 Kč additional
- AI-assisted analysis
- Included
Who Is This For?
Adults with multiple moles, family or personal history of melanoma, high sun exposure, or immunosuppression seeking an annual skin cancer screening baseline.
What's Included
Preparation Required
Arrive with clean, moisturiser-free skin. Remove nail polish (fingernails and toenails are part of the examination). Do not apply fake tan before the appointment. Bring any previous dermoscopy reports if transferring from another clinic.
Full-body digital dermoscopy: 3,000 Kč. Surgical mole removal (if required): from 1,300 Kč additionally. Performed by a dermatologist using the FotoFinder digital dermoscopy system.
- Category
- Diagnostic
- Duration
- 45 min
"{"author":"Eliška Macinková","text":"After two and a half years seeking help from seven doctors without answers, this physician changed everything..."
